SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Genta, Inc. (GNTA)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1870 44 0 GNTA
Emcee:  John Nobrega Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1795the drug still has possibilities IMO but there's definitely lots of wild carbob zagorin-5/4/2004
1794I jumped in late Friday after the big drop after reading some Yahoo posts about 613-5/4/2004
1793Ken, the term "increased toxicity" used in describing Genasense troublArt Bechhoefer-5/4/2004
1792Ken-->>This is a major over-reaction and one sided advantage to shorts.<Art Bechhoefer-5/4/2004
1791Aventis-FDA body says Genasense not effective Tuesday May 4, 2:06 am ET PARIS,Ken S.-5/4/2004
1790FDA gets tough as Genta drug is rejected By Victoria Griffith in Boston PublisKen S.-5/4/2004
1789Art, I didn't like how the FDA handled their independent report. They posteKen S.-5/3/2004
1788Art, the company announcement agrees with you. It isn't over and the statistKen S.-5/3/2004
1787FDA Advisory Committee Reviews Genasense™ For Use in Advanced Melanoma BERKELEYKen S.-5/3/2004
1786The reaction to the advisory panel may delay approval by the FDA, as happened wiArt Bechhoefer-5/3/2004
1785FDA NOT CONVINCED OF EFFICACY OF TWO POTENTIAL ONCOLOGY DRUGS; GENTA, ALLOS SHARKen S.-5/3/2004
1784FDA Concerns Shake Genta By Will Swarts TheStreet.com Staff Reporter 4/30/2004Ken S.-5/2/2004
1783Genta, Allos Both Hurt By FDA Briefing Documents By Kim Coghill Washington EKen S.-5/1/2004
1782Aventis/Genta Genasense Second Confirmatory Trial In Melanoma May Be Needed, FDAKen S.-4/30/2004
1781UPDATE - Aventis, Genta cancer drug data questioned Friday April 30, 5:04 pm ET Ken S.-4/30/2004
1780FDA Reviewer's Conclusion 6.2 Conclusions and Recommendations The sKen S.-4/30/2004
1779Genta Dn 37%; FDA Issues Briefing On Cancer Drug Genasense DOW JONES NEWSWIRES AJim Oravetz-4/30/2004
1778Nice call.tommtn-4/30/2004
1777Genta Announces 1st Quarter 2004 Financial Results and Highlights BERKELEY HEIGKen S.-4/30/2004
1776Rydex Biotech fund manger likes Genta, Ariad, Vertex By Jon Friedman Last UpdKen S.-4/30/2004
1775Kingsley Coach, Inc. Featured In `Larry Oakley's Comment' at WallStreetCKen S.-4/29/2004
1774fwiw, i sold all my gnta today at 15.40. sitting on a vg profit and decided to tbob zagorin-4/28/2004
1773More Volatility Seen in Biotech By MARCELO PRINCE DOW JONES NEWSWIRES April 28Ken S.-4/28/2004
1772Genta Incorporated Announces Conference Call to Discuss First Quarter 2004 EarniKen S.-4/27/2004
1771major story in WSJ monday will feature genansense. should move the stock. here&#bob zagorin-4/26/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News